Skip to main content

Journal Club - August 12, 2021

TTM2 Trial

Dr. Ian Pitcher presented the TTM2 Trial, which is an open-label trial with blinded assessment of outcomes comparing targeted hypothermia at 33°C, followed by controlled rewarming to targeted normothermia with early treatment of fever among patients with coma who had had an out-of-hospital cardiac arrest of presumed cardiac or unknown cause. This trial was published in NEJM in June of this year.

CCI is an inclusive centre with multidisciplinary membership for all cardiovascular investigators in BC